Bellicum Pharmaceuticals, Inc.

Bellicum Pharmaceuticals, Inc. company information, Employees & Contact Information

Bellicum Pharmaceuticals, located near the Houston Medical Center, is engineering high-performance cellular immunotherapies and unleashing their power against a wide range of cancers, impacting more patients than ever. Our cellular platform technology is designed to break through significant clinical barriers and activate the full power of cellular immunotherapies, with a focus on chimeric antigen receptor T-cell therapy (CAR-T).

Company Details

Employees
21
Founded
-
Address
3730 Kirby Dr,
Phone
(832) 384-1100
Email
in****@****cum.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Houston, Texas
Looking for a particular Bellicum Pharmaceuticals, Inc. employee's phone or email?

Bellicum Pharmaceuticals, Inc. Questions

News

MD Anderson acquires inducible switch technologies for cell therapy - MD Anderson Cancer Center

MD Anderson acquires inducible switch technologies for cell therapy MD Anderson Cancer Center

Bellicum's GoCAR-Ts crash out of clinic over safety signal, sparking search for strategic alternatives - Fierce Biotech

Bellicum's GoCAR-Ts crash out of clinic over safety signal, sparking search for strategic alternatives Fierce Biotech

Bellicum Pharmaceuticals Finalizes Sale and Approves Dissolution - TipRanks

Bellicum Pharmaceuticals Finalizes Sale and Approves Dissolution TipRanks

Bellicum (BLCM) Down on Ending Development of CAR-T Candidates - Yahoo Finance

Bellicum (BLCM) Down on Ending Development of CAR-T Candidates Yahoo Finance

Bellicum Pharmaceuticals ends CAR-T trials for solid tumors after risk-benefit review - Healio

Bellicum Pharmaceuticals ends CAR-T trials for solid tumors after risk-benefit review Healio

Bellicum Walks Away From GoCAR-T Cell Clinical Trials in Prostate Cancer, Solid Tumors - CGTLive®

Bellicum Walks Away From GoCAR-T Cell Clinical Trials in Prostate Cancer, Solid Tumors CGTLive®

Bellicum Weighs Options After Serious Safety Concerns Halt Only Trials - BioSpace

Bellicum Weighs Options After Serious Safety Concerns Halt Only Trials BioSpace

Bellicum Pharmaceuticals: Q3 Earnings Snapshot - qz.com

Bellicum Pharmaceuticals: Q3 Earnings Snapshot qz.com

It's Unlikely That Bellicum Pharmaceuticals, Inc.'s (NASDAQ:BLCM) CEO Will See A Huge Pay Rise This Year - Nasdaq

It's Unlikely That Bellicum Pharmaceuticals, Inc.'s (NASDAQ:BLCM) CEO Will See A Huge Pay Rise This Year Nasdaq

Bellicum sells assets to MD Anderson, moves towards liquidation (OTCMKTS:BLCM) - Seeking Alpha

Bellicum sells assets to MD Anderson, moves towards liquidation (OTCMKTS:BLCM) Seeking Alpha

Clinical holds for cell and gene therapy trials: Risks, impact, and lessons learned - ScienceDirect.com

Clinical holds for cell and gene therapy trials: Risks, impact, and lessons learned ScienceDirect.com

FDA Imposes Clinical Hold on Bellicum Lead Candidate BPX-501 - Genetic Engineering and Biotechnology News

FDA Imposes Clinical Hold on Bellicum Lead Candidate BPX-501 Genetic Engineering and Biotechnology News

BLCM News Today | Why did Bellicum Pharmaceuticals stock go up today? - MarketBeat

BLCM News Today | Why did Bellicum Pharmaceuticals stock go up today? MarketBeat

MD Anderson and Bellicum announce additional license agreement for use of CaspaCIDe® safety switch - MD Anderson Cancer Center

MD Anderson and Bellicum announce additional license agreement for use of CaspaCIDe® safety switch MD Anderson Cancer Center

Bellicum shares nose-dive on poor CAR-T data, program pause—company axes 79% of staffers - Fierce Biotech

Bellicum shares nose-dive on poor CAR-T data, program pause—company axes 79% of staffers Fierce Biotech

Bellicum Pharmaceuticals Appoints New CEO During Dissolution - TipRanks

Bellicum Pharmaceuticals Appoints New CEO During Dissolution TipRanks

After FDA setback, Bellicum bolsters R&D team with ex-Genentech executive - Fierce Biotech

After FDA setback, Bellicum bolsters R&D team with ex-Genentech executive Fierce Biotech

Genentech oncology head jumps ship to Bellicum as CEO - Fierce Biotech

Genentech oncology head jumps ship to Bellicum as CEO Fierce Biotech

Top Bellicum Pharmaceuticals, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant